Last updated: 2026-09-05 05:56:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Clearmind Medicine Inc. (CMND) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $1.19, with a market capitalization of $2.75M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.19 to $524.00. This page covers its latest market performance, valuation, price trends and company information.
$2.75M | |
$1.50 | |
$73,200.00 | |
$1.19 | |
$1.70 | |
15.20M | |
-- | |
-- | |
$524.00 | |
$1.19 | |
-- | |
-- |
Clearmind Medicine Inc. (CMND) last closed at $1.70 as of 2026-09-05 00:00:00, unchanged from the previous close of $1.70.
During the latest regular trading session, CMND traded between $1.19 and $73,200.00, with a volume of 15.20M shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Clearmind Medicine Inc. (CMND) moved from $1.82 to $1.19, representing a decline of 34.73% ($0.63).
The stock traded between $1.19 and $2.29 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 2.38 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0.0%
CMND is currently trading at $1.19, placing it 0.0% of the way from its 52-week low of $1.19 to its 52-week high of $524.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.
| Employees | 2 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Clearmind Medicine Inc. (CMND) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.